Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Sri Trang Gloves (Thailand) Public Company Limited (STGT.BK)
Hat Yai, TH
Sri Trang Gloves (Thailand) Public Company Limited, together with its affiliated companies, operates as a global producer and supplier of rubber gloves. Its extensive operations cover markets in Thailand, Singapore, the United States, China, Germany, Brazil, Japan, and other international regions. The company's business model is structured around two main divisions: Gloves and Other Businesses. It offers a wide array of disposable gloves, including natural latex and nitrile examination gloves, which come in powdered and powder-free varieties and are sold under various brand names. These products cater to diverse sectors such as healthcare, medical, food processing and handling, industrial manufacturing, and general lifestyle applications. Beyond its core glove manufacturing, the company also participates in the engineering sector, manages rental properties, and engages in financial asset management and investment activities. Established in 1989, the firm's main office is located in Hat Yai, Thailand. Sri Trang Gloves (Thailand) Public Company Limited functions as a subsidiary of Sri Trang Agro-Industry Public Company Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.45% | +10.09% | +12.15% | +31.15% | +75.18% | +30.43% | +63.27% | +34.08% | -73.63% | -64.71% | -64.71% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-4.5% Q1'26: -16.2% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-110.9% Q1'26: -6.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+9.8% Q1'26: +0.4% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%-0.6% Q1'26: +2.7% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%-0.4% Q1'26: +1.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.4% ★ Q1'26: +0.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.00× Q1'26: 1.56× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 2 EPS Ana. |
Dec 2027 3 Rev. Ana. 2 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
30.41B
est: 30.41B (+0.0%)
|
47.55B
est: 48.23B (-1.4%)
|
23.30B
est: 20.73B (+12.4%)
|
19.67B
est: 21.83B (-9.9%)
|
25.00B
est: 37.06B (-32.5%)
|
23.89B
est: 25.09B (-4.8%)
|
33.43B
23.23B – 48.24B
+33.2% YoY
|
35.24B
24.34B – 49.85B
+5.4% YoY
|
36.65B
35.04B – 38.27B
+4.0% YoY
|
| EBITDA |
17.20B
est: 9.34B (+84.2%)
|
27.25B
est: 14.81B (+83.9%)
|
3.52B
est: 6.37B (-44.7%)
|
2.15B
est: 4.65B (-53.7%)
|
3.42B
est: 7.89B (-56.7%)
|
2.25B
est: 5.34B (-57.9%)
|
7.12B
4.94B – 10.27B
+33.2% YoY
|
7.50B
5.18B – 10.61B
+5.4% YoY
|
7.80B
7.46B – 8.15B
+4.0% YoY
|
| EBIT |
16.11B
est: 7.57B (+112.8%)
|
26.00B
est: 12.00B (+116.6%)
|
2.07B
est: 5.16B (-59.9%)
|
476.87M
est: 3.09B (-84.6%)
|
1.37B
est: 5.25B (-73.9%)
|
-147.31M
est: 3.56B (-104.1%)
|
4.74B
3.29B – 6.84B
+33.2% YoY
|
4.99B
3.45B – 7.06B
+5.4% YoY
|
5.19B
4.97B – 5.42B
+4.0% YoY
|
| Net Income |
14.40B
est: 14.09B (+2.2%)
|
23.70B
est: 25.40B (-6.7%)
|
1.65B
est: 1.59B (+3.8%)
|
152.69M
est: 530.34M (-71.2%)
|
995.33M
est: 971.46M (+2.5%)
|
-108.59M
est: 708.27M (-115.3%)
|
1.43B
1.01B – 1.62B
+101.4% YoY
|
1.57B
977.56M – 1.92B
+10.4% YoY
|
2.22B
904.70M – 2.45B
+41.3% YoY
|
| SGA |
1.10B
est: 2.24B (-50.9%)
|
2.24B
est: 3.55B (-36.9%)
|
2.40B
est: 1.53B (+57.2%)
|
2.22B
est: 1.68B (+32.1%)
|
1.73B
est: 2.85B (-39.2%)
|
1.25B
est: 1.93B (-35.4%)
|
2.57B
1.79B – 3.71B
+33.2% YoY
|
2.71B
1.87B – 3.83B
+5.4% YoY
|
2.82B
2.69B – 2.94B
+4.0% YoY
|
| EPS |
5.94
est: 4.92 (+20.8%)
|
8.29
est: 8.87 (-6.5%)
|
0.58
est: 0.56 (+4.4%)
|
0.05
est: 0.19 (-71.2%)
|
0.35
est: 0.30 (+16.7%)
|
-0.04
est: 0.23 (-116.5%)
|
0.46
0.35 – 0.57
+100.5% YoY
|
0.51
0.34 – 0.67
+10.1% YoY
|
0.66
0.32 – 0.86
+30.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.02% | 172.5K | 0.65% |
| 2 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 90.8K | 0.26% |
| 3 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 40.2K | 0.48% |
| 4 | Vanguard FTSE Global All Cap ex Canada Index ETF VXC.TO | 0.00% | 7.2K | 0.22% |
| 5 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 21.7K | 0.22% |
| 6 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 11.7K | 0.22% |
| 7 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 5.1K | 0.22% |
| 8 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 593.15 | 0.22% |
| 9 | Vanguard Retirement Income ETF Portfolio VRIF.TO | 0.00% | 194.89 | 0.31% |
| 10 | Vanguard Conservative Income ETF Portfolio VCIP.TO | 0.00% | 92.81 | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jarinya Jirojkul | Chief Executive Officer & Director | 1M | female |
| Chia Chee Ping | Chief Marketing Officer & Director | 1M | male |
| Thanawan Sa-Ngiamsak | Chief Financial Officer & Director | 1M | female |
| Patcharee Kosanam | Company Secretary | — | female |
| Preenaphan Tanteerapolchai | Assistance Sustainability Manager | — | female |
| Somrat Thapnual | Human Resource Manager | — | male |
| Oralak Thinnakornsutibut | Finance & Account Manager and Accountant | — | female |
| Narungsri Chiranakorn | Head of Internal Audit | — | female |
| Apinya Assavasrisilp | Head of Investor Relations | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for STGT.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
